Decreased infectivity of a neutralization-resistant equine infectious anemia virus variant can be overcome by efficient cell-to-cell spread

Journal of Virology

Volumn 85, Issue 19, 2011, Pages 10421-10424

  Wu, Wuwei ^a   Blythe, Derek C ^b   Loyd, Hyelee ^a   Mealey, Robert H ^c   Tallmadge, Rebecca L ^c,d   Dorman, Karin S ^a,b   Carpenter, Susan ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b Department of Statistics Center for Statistics and Applications in Forensic Evidence Iowa State University 2438 Osborn Dr Ames   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; NEUTRALIZING ANTIBODY; PLASMID DNA; VIRUS DNA;

ASSAY; CELL SPREADING; COPY NUMBER VARIATION; DISEASE COURSE; DNA TEMPLATE; EQUINE INFECTIOUS ANEMIA VIRUS; GROWTH CURVE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; LENTIVIRINAE; MICROBIAL ACTIVITY; NONHUMAN; NOTE; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SCORING SYSTEM; VIRAL GENETICS; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; INFECTIOUS ANEMIA VIRUS, EQUINE; MUTATION; NEUTRALIZATION TESTS; VIRULENCE;

EQUINE INFECTIOUS ANEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS;

EID: 80053953709     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05349-11     Document Type: Note

References (14)

1. Ball, J. M., K. E. Rushlow, C. J. Issel, and R. C. Montelaro. 1992. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies. J. Virol. 66:732-742.
2. Bangham, C. R. 2003. The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. J. Gen. Virol. 84:3177-3189.
3. Carr, J. M., H. Hocking, P. Li, and C. J. Burrell. 1999. Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes. Virology 265:319-329.
4. Gupta, P., R. Balachandran, M. Ho, A. Enrico, and C. Rinaldo. 1989. Cellto-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody. J. Virol. 63:2361-2365.
5. Hotzel, I. 2003. Conservation of the human immunodeficiency virus type 1 gp120 V1/V2 stem/loop structure in the equine infectious anemia virus (EIAV) gp90. AIDS Res. Hum. Retroviruses 19:923-924.
6. Howe, L., C. Leroux, C. J. Issel, and R. C. Montelaro. 2002. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. J. Virol. 76:10588-10597.
7. Igakura, T., et al. 2003. Spread of HTLV-I between lymphocytes by virusinduced polarization of the cytoskeleton. Science 299:1713-1716.
8. Joos, B., et al. 2005. Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions. J. Virol. 79:9026-9037.
9. Lobritz, M. A., A. J. Marozsan, R. M. Troyer, and E. J. Arts. 2007. Natural variation in the V3 crown of human immunodeficiency virus type 1 affects replicative fitness and entry inhibitor sensitivity. J. Virol. 81:8258-8269.
10. Marozsan, A. J., et al. 2005. Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry. J. Virol. 79:7121-7134.
11. Rangel, H. R., et al. 2003. Role of the human immunodeficiency virus type 1 envelope gene in viral fitness. J. Virol. 77:9069-9073.
12. Sponseller, B. A., et al. 2007. Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease. Virology 363:156-165.
13. Tallmadge, R. L., et al. 2008. Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus. Clin. Vaccine Immunol. 15:1138-1140.
14. Taylor, S. D., S. R. Leib, S. Carpenter, and R. H. Mealey. 2010. Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses. J. Virol. 84:6536-6548.